摘要
背景:人们越来越注重营养法治疗阿尔茨海默病(AD),并存在有关AD和同型半胱氨酸(同型半胱氨酸),维生素B12和叶酸水平之间的关联的争议。目的:本研究评估AD和半胱氨酸的结合的水平,维生素B12和叶酸之间的关联。方法:本病例对照研究包括115例AD患者和115匹配的对照。血清叶酸和维生素B12是使用自动免疫分析仪测定的。用高效液相色谱法对血浆同型半胱氨酸进行测定。调整年龄和性别后,使用二进制逻辑回归对 AD和同型半胱氨酸,维生素B12和叶酸之间的关联进行了分析。结果:与正常血中同型半胱氨酸,维生素B12和叶酸水平作为参考相结合,正常者同型半胱氨酸和叶酸低维生素B12与AD相关(调整后的比值比[OR],4.6;95%置信区间[CI]:1.6-13.2)。低维生素B12和叶酸正常者同型半胱氨酸的结合AD有关联(调整OR,4.3;95%CI:1.3-14.6)。高Hcy与患者正常的维生素B12低叶酸水平的结合AD有关联(调整OR,17.0;95%CI:5.4-53.4)。高同型半胱氨酸,低维生素B12和叶酸的任何水平的结合AD有关联(调整OR,30.5;95%CI:9.7-95.9)。结论:维生素B12直接与AD相关。高同型半胱氨酸,低维生素B12和叶酸的任何水平的组合显示与AD最弱的关联。
关键词: 日常生活活动,阿尔茨海默氏病,叶酸,同型半胱氨酸,简短智能测验,维生素B12。
Current Alzheimer Research
Title:Associations between Alzheimer’s Disease and Blood Homocysteine, Vitamin B12, and Folate: A Case-Control Study
Volume: 12 Issue: 1
Author(s): Hui Chen, Shuai Liu, Lu Ji, Tianfeng Wu, Fei Ma, Yong Ji, Yuying Zhou, Miaoyan Zheng, Meilin Zhang and Guowei Huang
Affiliation:
关键词: 日常生活活动,阿尔茨海默氏病,叶酸,同型半胱氨酸,简短智能测验,维生素B12。
摘要: Background: There is a growing focus on nutritional therapy for Alzheimer’s disease (AD), and controversy exists regarding the association between AD and homocysteine (Hcy), vitamin B12, and folate levels. Objective: The present study evaluated the association between AD and the combined levels of Hcy, vitamin B12, and folate. Methods: This case-control study consisted of 115 patients with AD and 115 matched controls. Serum folate and vitamin B12 were measured using an automated immunoassay analyzer. Plasma Hcy was measured using high-performance liquid chromatography. The association between AD and Hcy, vitamin B12, and folate was analyzed using binary logistic regression, adjusted for age and sex. Results: With the combination of normal blood Hcy, vitamin B12, and folate levels as the reference category, low vitamin B12 in subjects with normal Hcy and folate was associated with AD (adjusted odds ratio [OR], 4.6; 95% confidence interval [CI]: 1.6–13.2). The combination of low vitamin B12 and folate in subjects with normal Hcy was associated with AD (adjusted OR, 4.3; 95% CI: 1.3–14.6). The combination of high Hcy and low folate levels in patients with normal vitamin B12 was associated with AD (adjusted OR, 17.0; 95% CI: 5.4– 53.4). The combination of high Hcy, low vitamin B12, and any folate level was associated with AD (adjusted OR, 30.5; 95% CI: 9.7–95.9). Conclusion: Vitamin B12 was directly associated with AD. The combination of high Hcy, low vitamin B12, and any folate level represented the poorest association with AD.
Export Options
About this article
Cite this article as:
Hui Chen, Shuai Liu, Lu Ji, Tianfeng Wu, Fei Ma, Yong Ji, Yuying Zhou, Miaoyan Zheng, Meilin Zhang and Guowei Huang , Associations between Alzheimer’s Disease and Blood Homocysteine, Vitamin B12, and Folate: A Case-Control Study, Current Alzheimer Research 2015; 12 (1) . https://dx.doi.org/10.2174/1567205012666141218144035
DOI https://dx.doi.org/10.2174/1567205012666141218144035 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Mechanisms Regulating mRNA Stability: Physiological and Pathological Significance
Current Genomics NAD+, Sirtuins, and Cardiovascular Disease
Current Pharmaceutical Design The Use of Carvedilol in Pediatric Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets A Review of Computational Identification of Protein Post-Translational Modifications
Mini-Reviews in Organic Chemistry Smoking and Hypertension: Independent or Additive Effects to Determining Vascular Damage?
Current Vascular Pharmacology MicroRNA Regulation in Cardiovascular Disease
Current Drug Targets Natural Products as a Source of Antiarrhythmic Drugs
Mini-Reviews in Medicinal Chemistry TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry Prediction Models and Scores in Adult Congenital Heart Disease
Current Pharmaceutical Design Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design The Emergent Cardiovascular Risk Factors and Organ Damage in Arterial Hypertension
Current Hypertension Reviews Fetzima (levomilnacipran), a Drug for Major Depressive Disorder as a Dual Inhibitor for Human Serotonin Transporters and Beta-Site Amyloid Precursor Protein Cleaving Enzyme-1
CNS & Neurological Disorders - Drug Targets A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches
Current Drug Targets Free Fatty Acids: Circulating Contributors of Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy
Current Pharmaceutical Design Dietary Interventions for Atopic Disorders
Current Pharmaceutical Design Mesenchymal Stem Cells as Mediators of Neural Differentiation
Current Stem Cell Research & Therapy An Umbrella Review of Nuts Intake and Risk of Cardiovascular Disease
Current Pharmaceutical Design